Iain D. Dukes

US·SEC (Form 4)

Iovance Biotherapeutics, Inc.Theseus Pharmaceuticals, Inc.Traws Pharma, Inc.

Total declarations

Companies

▲ Purchases (2 ops.)

€331k

▼ Sales (0 ops.)

—

Latest filing published 16 Dec 2025 for Traws Pharma, Inc.. Read the official filing

Filing timeline

BuySale

Iain D. Dukes

Insider track record

Disclosed buys

Disclosed sells

Signal history

Closed purchases

Market purchases

Positive at T+90

50%

Median T+90

-8.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Iovance Biotherapeutics, INC. 2 purchases · last 20 Feb 2024

Since each purchase

Iovance Biotherapeutics, Inc.
Filed 20 Feb 2024 · 971 days ago · €272k
-64.4%
Entry US$15.77 · Close at T+365 US$5.61
Iovance Biotherapeutics, Inc.
Filed 28 Nov 2022 · 1420 days ago · €59k
-7.5%
Entry US$6.14 · Close at T+365 US$5.68

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Iain D. Dukes: trading record in brief

Filings by Iain D. Dukes span 3 companies, the busiest being Traws Pharma, Inc., Iovance Biotherapeutics, Inc. and Theseus Pharmaceuticals, Inc. In total, 6 filings cover trades dated from 23 November 2022 to 12 December 2025.

Purchases make up the whole of the open-market record (2 purchases, €331k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants.

The newest entry dates from 16 December 2025: a share grant, in Traws Pharma, Inc. The last insider purchase was made public on 20 February 2024, 971 days ago. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.